Hey Mozz,
Great article, thanks for posting.
The first sentence says 'Paradigm's success is highly dependent on their exclusive supply agreement with BPC', and 'no other pharma group may reference the DMF in a future submission without BPC approval.'
The first sentence implies that it's Bene that hold the keys to the Castle, not Paradigm. Does 'highly dependent' mean "locked in watertight"? Also, I seem to recall that the exclusive agreement applies to some territories, but not worldwide. And if/when this is finally approved, what if Bene give permission to another Pharma to reference the DMF?
To put it another way, is there a chance that PAR do all this work, get it to approval, but somehow get shafted just before the winning post?
(I appreciate your attention is much more likely to be taken with the DMOAD announcement that's about to drop!)
- Forums
- ASX - By Stock
- PAR
- Ann: Trading Halt
Ann: Trading Halt, page-62
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
-0.015(4.84%) |
Mkt cap ! $103.1M |
Open | High | Low | Value | Volume |
30.5¢ | 30.5¢ | 29.5¢ | $86.19K | 286.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 70151 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 60669 | 0.295 |
4 | 17897 | 0.290 |
2 | 33508 | 0.285 |
2 | 100000 | 0.280 |
5 | 42556 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18600 | 1 |
0.315 | 52964 | 5 |
0.320 | 70187 | 4 |
0.325 | 48316 | 3 |
0.330 | 56660 | 4 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |